about
Poly Cystic Ovarian Syndrome: An Updated OverviewReduced expression of the murine p85alpha subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetesUtility of the modified ATP III defined metabolic syndrome and severe obesity as predictors of insulin resistance in overweight children and adolescents: a cross-sectional studyObesity and Polycystic Ovary Syndrome.The circadian variation in Anti-Müllerian hormone in patients with polycystic ovary syndrome differs significantly from normally ovulating women.GnRH pulsatility, the pituitary response and reproductive dysfunctionPolycystic ovary syndrome in the pediatric populationInsulin dynamics in young women with polycystic ovary syndrome and normal glucose tolerance across categories of body mass indexThiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS).Ovarian hypertension: polycystic ovary syndrome.Adverse pregnancy outcomes with assisted reproductive technology in non-obese women with polycystic ovary syndrome: a case-control studyEffects of High Intensity Interval Training and Strength Training on Metabolic, Cardiovascular and Hormonal Outcomes in Women with Polycystic Ovary Syndrome: A Pilot StudyInsulin resistance in women with hirsutismMetabolic effects of polycystic ovary syndrome in adolescents.Cardiometabolic aspects of the polycystic ovary syndrome.PPAR Gamma: Coordinating Metabolic and Immune Contributions to Female Fertility.Is insulin resistance an intrinsic defect in asian polycystic ovary syndrome?Prenatal androgen excess negatively impacts body fat distribution in a nonhuman primate model of polycystic ovary syndromePancreatic β-cell dysfunction in polycystic ovary syndrome: the role of metforminOntogeny of polycystic ovary syndrome and insulin resistance in utero and early childhoodSerum C-reactive protein levels in normal-weight polycystic ovary syndrome.Prevalence of the metabolic syndrome in Asian women with polycystic ovary syndrome: using the International Diabetes Federation criteria.PHYSIOLOGY AND ENDOCRINOLOGY SYMPOSIUM: Insulin action and lipotoxicity in the development of polycystic ovary syndrome: A review.Should insulin resistance be screened in lean hirsute women?Effects of metformin treatment on luteal phase progesterone concentration in polycystic ovary syndrome.Chronic-intermittent cold stress in rats induces selective ovarian insulin resistance.Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects.Study of association of IRS-1 and IRS-2 genes polymorphisms with clinical and metabolic features in women with polycystic ovary syndrome. Is there an impact?Serum visfatin in Asian women with polycystic ovary syndrome.Low free plasma levels of retinol-binding protein 4 in insulin-resistant subjects with polycystic ovary syndrome.Insulin resistance in nonobese Japanese women with polycystic ovary syndrome is associated with poorer glucose tolerance, delayed insulin secretion, and enhanced insulin response.Assessment of insulin resistance in Chinese PCOS patients with normal glucose tolerance.[Insulin resistance and metabolic profile in lean and overweight/obese polycystic ovary syndrome patients].Surface-enhanced Raman scattering for the detection of polycystic ovary syndrome.Role of Lipotoxicity and Contribution of the Renin-Angiotensin System in the Development of Polycystic Ovary Syndrome.
P2860
Q26752564-6BA7B175-E8AA-4BBB-AF0B-BA6E5A3E73FDQ28344700-10C32A58-792D-48D6-ADC1-446C88598D9CQ33273785-1FF4C139-E12B-40B2-B3B7-EE72A97DD63BQ33820057-8B9EB057-05D0-411C-AC09-CFBD7F801EFFQ34983821-30FA9CE5-6698-4760-8DD5-0F9FD72FF6F2Q35018258-37D52FFB-FBBE-4B47-BF7D-EA70025141D1Q35075035-5B76C677-E6B1-4832-8C9F-A1D7A503626EQ35140103-4EB449DB-3B62-49C1-9126-F38DEF1C8D0DQ35606054-64C419C0-C8F0-4EDB-95BD-45F3EBB43F1BQ35660296-A97123D9-9D4A-460E-86CA-19AD9FF6B788Q35767806-26C93854-77C3-498F-A257-2DC49DA3BFFCQ35787725-00C38909-386F-4A94-9372-DC438A9B21E6Q35990483-10B140EB-C4A6-4186-ABD9-8F706CB07EE5Q36215758-A6C25268-AFA1-4A73-9B11-46CC7BBB3B45Q36287892-41487165-0C58-4CBB-AFFD-75403D51FF79Q36465006-7A79945E-EFC7-4E9E-B14D-D4E581AA3185Q36793092-A3602301-A01F-476D-ABA5-2E96E0759133Q37001625-F2731B65-7F6E-4CD2-998B-324408C5F6DEQ37044215-642DEC96-B997-46D3-9116-C21D61B74B64Q37067105-2CB3A53B-DA70-47F7-B6BA-8E2CD0956A4EQ37445314-1CD17295-EE85-44BA-A10D-38A440083B69Q38302430-A4FBAA35-687E-4FAD-9253-CAA48F28DCAAQ38861206-1E76F56F-441C-4A53-B2DA-C6EE5A01CFE1Q40247441-9FAC6F1D-DC64-475B-934D-F9A90D3BA67BQ42165613-290F302E-AFA9-4208-8609-A7171C162537Q42443274-376D1032-1831-440C-ADB3-1D9A95CBD4EBQ42471841-20AD4D2C-A2BB-43A4-8E29-E2584FAFAD4CQ43139153-44CC865E-2759-440D-9A12-AE7A097BBB79Q45966116-A7E2E525-070B-4BD9-AB6B-8311D33907B1Q46147587-D2A7856B-5689-43C2-9CBF-24F38D5BF376Q47118292-B99C361D-D055-418A-AEBF-A5B512EF0CE9Q50546791-C923261D-E975-4AC6-90E1-D1D9090642F9Q51481042-5983AB9F-41C9-48DB-BA2B-82892DC75B80Q55311749-D6036EE6-CC16-4CCB-B897-D200A22E1A1EQ55403020-592AC7B5-DE2E-49A5-A8C7-546EA8164C92
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Insulin action in the polycystic ovary syndrome.
@ast
Insulin action in the polycystic ovary syndrome.
@en
type
label
Insulin action in the polycystic ovary syndrome.
@ast
Insulin action in the polycystic ovary syndrome.
@en
prefLabel
Insulin action in the polycystic ovary syndrome.
@ast
Insulin action in the polycystic ovary syndrome.
@en
P1476
Insulin action in the polycystic ovary syndrome.
@en
P2093
P304
P356
10.1016/S0889-8529(05)70073-6
P577
1999-06-01T00:00:00Z